Immunotherapy for pediatric brain tumors: past and present

被引：31

作者：

Foster, Jessica B. ^{[1
,2
]}

Madsen, Peter J. ^{[3
]}

Hegde, Meenakshi ^{[4
,5
]}

Ahmed, Nabil ^{[4
,5
]}

Cole, Kristina A. ^{[1
,2
]}

Maris, John M. ^{[1
,6
]}

Resnick, Adam C. ^{[3
,7
]}

Storm, Phillip B. ^{[3
,7
]}

Waanders, Angela J. ^{[8
]}

机构：

[1] Childrens Hosp Philadelphia, Div Oncol, Philadelphia, PA 19104 USA

[2] Childrens Hosp Philadelphia, Ctr Childhood Canc Res, Philadelphia, PA 19104 USA

[3] Childrens Hosp Philadelphia, Div Neurosurg, Philadelphia, PA 19104 USA

[4] Texas Childrens Hosp, Texas Childrens Canc Ctr, Houston, TX 77030 USA

[5] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA

[6] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA

[7] Childrens Hosp Philadelphia, Ctr Data Driven Discovery Biomed, Philadelphia, PA 19104 USA

[8] Ann & Robert H Lurie Childrens Hosp Chicago, Div Oncol, Chicago, IL 60611 USA

来源：

NEURO-ONCOLOGY | 2019年 / 21卷 / 10期

关键词：

brain tumor; immunotherapy; pediatric; ACTIVATED KILLER-CELLS; WT1 PEPTIDE VACCINATION; MALIGNANT PRIMARY BRAIN; T-CELLS; ADOPTIVE IMMUNOTHERAPY; ANTIGEN PEPTIDES; HEMATOLOGICAL MALIGNANCIES; IMMUNE-RESPONSES; YOUNG-ADULTS; GLIOBLASTOMA;

D O I：

10.1093/neuonc/noz077

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

The field of cancer immunotherapy has progressed at an accelerated rate over the past decade. Pediatric brain tumors thus far have presented a formidable challenge for immunotherapy development, given their typically low mutational burden, location behind the blood-brain barrier in a unique tumor microenvironment, and intratumoral heterogeneity. Despite these challenges, recent developments in the field have resulted in exciting preclinical evidence for various immunotherapies and multiple clinical trials. This work reviews the history and advances in active immunotherapy, checkpoint blockade, and adoptive T-cell therapy for pediatric brain tumors, including ongoing clinical trials.

引用

页码：1226 / 1238

页数：13

共 50 条

[21] Targeted immunotherapy for pediatric solid tumors
Kopp, Lisa M.
Katsanis, Emmanuel
ONCOIMMUNOLOGY, 2016, 5 (03):
[22] Inhibition of cyclooxygenase-2 enhances immunotherapy against experimental brain tumors
Eberstal, Sofia
Badn, Wiaam
Fritzell, Sara
Esbjornsson, Magnus
Darabi, Anna
Visse, Edward
Siesjo, Peter
CANCER IMMUNOLOGY IMMUNOTHERAPY, 2012, 61 (08) : 1191 - 1199
[23] Pediatric brain tumors
Poussaint, Tina Y.
Panigrahy, Ashok
Huisman, Thierry A. G. M.
PEDIATRIC RADIOLOGY, 2015, 45 : 443 - 453
[24] Pediatric brain tumors
Tina Y. Poussaint
Ashok Panigrahy
Thierry A. G. M. Huisman
Pediatric Radiology, 2015, 45 : 443 - 453
[25] Pediatric Brain Tumors
Brandao, Lara A.
Poussaint, Tina Young
NEUROIMAGING CLINICS OF NORTH AMERICA, 2013, 23 (03) : 499 - +
[26] Microglia in pediatric brain tumors The missing link to successful immunotherapy
du Chatinier, Aimee
Velilla, Irene Querol
Meel, Michael Hananja
Hoving, Eelco Wieger
Hulleman, Esther
Metselaar, Dennis Serge
CELL REPORTS MEDICINE, 2023, 4 (11)
[27] Immunotherapy for brain metastases and primary brain tumors
Giacomo, Anna M. Di
Mair, Maximilian J.
Ceccarelli, Michele
Anichini, Andrea
Ibrahim, Ramy
Weller, Michael
Lahn, Michael
Eggermont, Alexander M. M.
Fox, Bernard
Maio, Michele
EUROPEAN JOURNAL OF CANCER, 2023, 179 : 113 - 120
[28] The future of cancer immunotherapy for brain tumors: a collaborative workshop
Brown, Christine E.
Bucktrout, Samantha
Butterfield, Lisa H.
Futer, Olga
Galanis, Evanthia
Hormigo, Adilia
Lim, Michael
Okada, Hideho
Prins, Robert
Marr, Sara Siebel
Tanner, Kirk
JOURNAL OF TRANSLATIONAL MEDICINE, 2022, 20 (01)
[29] Role of immunotherapy in bladder cancer: past, present and future
Butt, Sabeeh-ur-Rehman
Malik, Laeeq
CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2018, 81 (04) : 629 - 645
[30] Cellular immunity and immunotherapy of brain tumors
Prins, RM
Liau, LM
FRONTIERS IN BIOSCIENCE-LANDMARK, 2004, 9 : 3124 - 3136

← 1 2 3 4 5 →